文献速递糖尿病

1型糖尿病患者平均血糖与目标范围内时间不一致及其与HbA1c的关系:GOLD与SILVER试验结果

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
PubMed 文献 · Diabetologia · 2024-04-26

基于GOLD试验144例和SILVER试验98例1型糖尿病成人患者随访2.5年的596对HbA1c与连续血糖监测配对数据,采用线性混合效应模型分析。平均血糖可解释HbA1c变异的63%,计入个体间差异后升至88%;目标范围内时间与HbA1c的关联受低于范围时间和高于范围时间2级影响,但计入平均血糖后均无显著关联。

要点

  • 平均血糖可解释HbA1c变异的63%(r=0.79,p<0.001),计入个体间差异后升至88%(r=0.94,p<0.001)。
  • 在给定平均血糖和目标范围内时间下,10%的个体HbA1c偏离估计值超过8 mmol/mol(0.8%)。
  • 给定目标范围内时间时,低于范围时间每增加1%与HbA1c降低0.6 mmol/mol相关(95%CI 0.4,0.9;p<0.001)。

核心结论

  • 平均血糖与HbA1c之间以及目标范围内时间与HbA1c之间存在个体间差异,在相对较大比例的1型糖尿病患者中可见具有临床意义的偏离。

研究设计与样本

  • 分析随机临床试验GOLD试验(n=144)和随访SILVER试验(n=98)中随访2.5年的1型糖尿病成人数据,共纳入596对HbA1c与连续血糖监测配对测量,采用线性混合效应模型处理重复测量数据的个体内相关性。

主要发现

  • GOLD试验参与者平均年龄±SD为44±13岁,女性63例(44%),平均HbA1c±SD为72±9.8 mmol/mol(8.7±0.9%)。
  • 平均血糖与HbA1c相关时,平均血糖解释HbA1c变异的63%(r=0.79,p<0.001);计入平均血糖与HbA1c关系的个体间差异后,解释比例升至88%(r=0.94,拟合改善p<0.001)。
  • 低于范围时间(<3.9 mmol/l)、高于范围时间2级(>13.9 mmol/l)和血糖变异性对平均血糖与HbA1c的关联影响很小或没有影响。
  • 在给定平均血糖和目标范围内时间下,10%的个体HbA1c偏离基于平均血糖和目标范围内时间与HbA1c总体关联的估计值超过8 mmol/mol(0.8%)。
  • 给定目标范围内时间时,低于范围时间每增加1%与HbA1c降低0.6 mmol/mol相关(95%CI 0.4,0.9;p<0.001),高于范围时间2级每增加2%与HbA1c升高0.4 mmol/mol相关(95%CI 0.1,0.6;p=0.003);但计入平均血糖后,目标范围内时间、低于范围时间和高于范围时间2级均与HbA1c无显著关联。

临床怎么用

  • 作者认为这些结果可为医疗保健提供者和糖尿病患者在预后及糖尿病管理决策方面提供重要信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Previous studies have shown that individuals with similar mean glucose levels (MG) or percentage of time in range (TIR) may have different HbA1c values. The aim of this study was to further elucidate how MG and TIR are associated with HbA1c. METHODS: Data from the randomised clinical GOLD trial (n=144) and the follow-up SILVER trial (n=98) of adults with type 1 diabetes followed for 2.5 years were analysed. A total of 596 paired HbA1c/continuous glucose monitoring measurements were included. Linear mixed-effects models were used to account for intra-individual correlations in repeated-measures data. RESULTS: In the GOLD trial, the mean age of the participants (± SD) was 44±13 years, 63 (44%) were female, and the mean HbA1c (± SD) was 72±9.8 mmol/mol (8.7±0.9%). When correlating MG with HbA1c, MG explained 63% of the variation in HbA1c (r=0.79, p<0.001). The variation in HbA1c explained by MG increased to 88% (r=0.94, p value for improvement of fit <0.001) when accounting for person-to-person variation in the MG-HbA1c relationship. Time below range (TBR; <3.9 mmol/l), time above range (TAR) level 2 (>13.9 mmol/l) and glycaemic variability had little or no effect on the association. For a given MG and TIR, the HbA1c of 10% of individuals deviated by >8 mmol/mol (0.8%) from their estimated HbA1c based on the overall association between MG and TIR with HbA1c. TBR and TAR level 2 significantly influenced the association between TIR and HbA1c. At a given TIR, each 1% increase in TBR was related to a 0.6 mmol/mol lower HbA1c (95% CI 0.4, 0.9; p<0.001), and each 2% increase in TAR level 2 was related to a 0.4 mmol/mol higher HbA1c (95% CI 0.1, 0.6; p=0.003). However, neither TIR, TBR nor TAR level 2 were significantly associated with HbA1c when accounting for MG. CONCLUSIONS/INTERPRETATION: Inter-individual variations exist between MG and HbA1c, as well as between TIR and HbA1c, with clinically important deviations in relatively large groups of individuals with type 1 diabetes. These results may provide important information to both healthcare providers and individuals with diabetes in terms of prognosis and when making diabetes management decisions.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Sterner Isaksson S, Imberg H, Hirsch IB, et al. Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials. Diabetologia. 2024. PMID: 38668761. doi:10.1007/s00125-024-06151-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。